048410 — Hyundai Bioscience Co Share News
0.000.00%
Last trade - 00:00- KR₩851bn
- KR₩828bn
- KR₩4bn
S.Korean vaccine firm SK Bioscience sees shares soar 30% on debut (updated)
Vaccine developer SK Bioscience to raise $1.3 bln in S.Korea's largest IPO since 2017 (updated)
Brief: Hyundai Bioscience Develops Injection Drug For Potential Treatment Of Severe Cases Of COVID-19
Brief: Hyundai Bioscience Says Co's COVID-19 Oral Drug Solved Niclosamide's Inhibitory Concentration Problem
Brief: Hyundai IBT to change co name to Hyundai Bioscience
Brief: Hyundai IBT to change co name to Hyundai Bioscience
Brief: Hyundai IBT signs contract worth 11.82 bln won
Brief: Hyundai IBT says conversion of 5th series convertible bonds into shares
Brief: Hyundai IBT to buy 24.5 pct stake in Vitabrid MENA Limited for 138.6 mln won